Therefore, if the therapeutic potential of MC receptor targeted treatments is further addressed in experimental models of hypertension, it will be important to control and limit the MC4-R-mediated effects on hemodynamics by using compounds that do not cross the blood–brain-barrier or activate MC4 receptors to a significant extent. The gene discussed is MC4R; the disease is hypertensive disorder.